Humacyte, Inc. (HUMA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
Humacyte (HUMA) Q1 2026: 25% Workforce Cut Unlocks $14.3M in Cost Savings as Commercial Pivot Accelerates
May 13, 2026
-
Humacyte (HUMA) Q4 2025: VAC Approval Rate Tops 70% as Symbeth Adoption Broadens
March 27, 2026
-
Humacyte (HUMA) Q3 2025: SimVest Revenue Jumps 7x as Hospital Adoption Accelerates
November 12, 2025
-
Humacyte (HUMA) Q2 2025: Hospital Access Expands 16x as SimVest Pricing Reset Drives Uptick
August 11, 2025
-
Humacyte (HUMA) Q1 2025: 45 Hospital Evaluations Signal SimVest Launch Momentum
July 06, 2025